Literature DB >> 24769492

Cryptic polyreactivity of IgG expressed by splenic marginal zone B-cell lymphoma.

Ankit Mahendra1, Bagirath Gangadharan2, Sébastien André2, Myriam Boudjoghra3, Frédéric Davi4, Maxime Lecerf2, Cyril Planchais2, Srinivas V Kaveri2, Sébastien Lacroix-Desmazes2, Jordan D Dimitrov5.   

Abstract

Polyreactive antibodies represent a significant fraction of immune repertoires and play an important role in the immune defense and immune homeostasis. Polyreactive B-cell receptors (BCR), however, are frequently expressed by B-cell lymphomas. It was suggested that polyreactive BCR on lymphoma cells might deliver stimulation signals by binding to various endogenous or exogenous antigens, thus promoting the survival of the malignant cells. In addition to natural polyreactive antibodies, immune repertoires contain antibodies that acquire polyreactivity after exposure to different redox-active substances such as reactive oxygen species, iron ions and heme. Here, we demonstrate that an antibody cloned from a patient's splenic marginal zone B-cell lymphoma acquires physiologically relevant binding affinity to various autoantigens following exposure to heme. We elucidated the mechanisms underlying polyreactive antigen binding. The results obtained in this study imply that antigen-binding receptors expressed on some malignant cells acquire polyreactivity after exposure to redox substances that are released at sites of inflammation or as a result of cellular damage. The acquisition of novel BCR specificities under hemolytic or inflammatory conditions may play an important role in the physiopathology of certain B-cell malignancies.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody polyreactivity; B cell lymphoma; Heme; Hemolysis; Immunoglobulins

Mesh:

Substances:

Year:  2014        PMID: 24769492     DOI: 10.1016/j.molimm.2014.03.009

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  1 in total

1.  The free heme concentration in healthy human erythrocytes.

Authors:  Anupam Aich; Melissa Freundlich; Peter G Vekilov
Journal:  Blood Cells Mol Dis       Date:  2015-09-21       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.